These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27115420)

  • 1. Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice.
    Machado V; Gilsbach R; Das R; Schober A; Bogatyreva L; Hauschke D; Krieglstein K; Unsicker K; Spittau B
    Cell Tissue Res; 2016 Aug; 365(2):209-23. PubMed ID: 27115420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Machado V; Haas SJ; von Bohlen Und Halbach O; Wree A; Krieglstein K; Unsicker K; Spittau B
    Neurobiol Dis; 2016 Apr; 88():1-15. PubMed ID: 26733415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease.
    Ren B; Zhang YX; Zhou HX; Sun FW; Zhang ZF; Wei Z; Zhang CY; Si DW
    J Neurol Sci; 2015 Jan; 348(1-2):142-52. PubMed ID: 25491263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degeneration?
    De Luca MA; Cauli O; Morelli M; Simola N
    J Neurochem; 2014 Nov; 131(3):284-9. PubMed ID: 24989117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.
    Strelau J; Sullivan A; Böttner M; Lingor P; Falkenstein E; Suter-Crazzolara C; Galter D; Jaszai J; Krieglstein K; Unsicker K
    J Neurosci; 2000 Dec; 20(23):8597-603. PubMed ID: 11102463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGF-2 deficiency does not alter vulnerability of the dopaminergic nigrostriatal system towards MPTP intoxication in mice.
    Zechel S; Jarosik J; Kiprianova I; Schober A; Unsicker K; von Bohlen und Halbach O
    Eur J Neurosci; 2006 Mar; 23(6):1671-5. PubMed ID: 16553632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE
    Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Cossetti C; D'Adamo P; Zardini E; Andreoni L; Ihekwaba AE; Serra PA; Franciotta D; Martino G; Pluchino S; Marchetti B
    Neurobiol Dis; 2011 Feb; 41(2):508-27. PubMed ID: 21056667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone Attenuates Neuroinflammation and Promotes Dopaminergic Neuronal Survival in the Nigrostriatal System of Rats after Diffuse Brain Injury.
    Liu M; Bachstetter AD; Cass WA; Lifshitz J; Bing G
    J Neurotrauma; 2017 Jan; 34(2):414-422. PubMed ID: 27142118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease.
    Yun HM; Choi DY; Oh KW; Hong JT
    Mol Neurobiol; 2015 Aug; 52(1):422-31. PubMed ID: 25193021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth/differentiation factor-15 (GDF-15), a novel member of the TGF-beta superfamily, promotes survival of lesioned mesencephalic dopaminergic neurons in vitro and in vivo and is induced in neurons following cortical lesioning.
    Strelau J; Schober A; Sullivan A; Schilling L; Unsicker K
    J Neural Transm Suppl; 2003; (65):197-203. PubMed ID: 12946057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression and recovery of Parkinsonism in a chronic progressive MPTP-induction model in the marmoset without persistent molecular and cellular damage.
    Franke SK; van Kesteren RE; Wubben JA; Hofman S; Paliukhovich I; van der Schors RC; van Nierop P; Smit AB; Philippens IH
    Neuroscience; 2016 Jan; 312():247-59. PubMed ID: 26431624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial depletion and repopulation of microglia have different effects in the acute MPTP mouse model of Parkinson's disease.
    Li Q; Shen C; Liu Z; Ma Y; Wang J; Dong H; Zhang X; Wang Z; Yu M; Ci L; Sun R; Shen R; Fei J; Huang F
    Cell Prolif; 2021 Aug; 54(8):e13094. PubMed ID: 34312932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.
    'Episcopo FL; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
    Curr Aging Sci; 2013 Feb; 6(1):45-55. PubMed ID: 23895521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity.
    Oeckl P; Ferger B
    Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.